Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Worldwide, Open Label, Clinical Trial to Examine the Long Term Safety and Tolerability of Rizatriptan in Pediatric Migraineurs for the Treatment of Migraine With or Without Aura

NCT01004263 is registered in ClinicalTrials.gov with Organon and Co as lead sponsor.

NCT NCT01004263
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01004263 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Worldwide, Open Label, Clinical Trial to Examine the Long Term Safety and Tolerability of Rizatriptan in Pediatric Migraineurs for the Treatment of Migraine With or Without Aura
Lead sponsor
Organon and Co
Phase
Phase 3
Overall status
Completed
Start date
December 1, 2009
Completion date
April 18, 2011
Enrollment
674 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

acute migraine with or without aura in adolescents